Filtros de búsqueda

Lista de obras de Bettina Wingelhofer

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

artículo científico publicado en 2017

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia

scientific article published on 06 September 2019

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas

artículo científico publicado en 2017

Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.

artículo científico publicado en 2014

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

artículo científico publicado en 2020

Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer

article

Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation

artículo científico publicado en 2017

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies

artículo científico publicado en 2017

Pharmacologic inhibition of STAT5 in acute myeloid leukemia.

artículo científico publicado en 2018

Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia

scientific article published on 28 November 2019

Preloading with L-BPA, L-tyrosine and L-DOPA enhances the uptake of [ 18 F]FBPA in human and mouse tumour cell lines

scientific article published on 01 September 2016

STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

artículo científico publicado en 2020

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.

artículo científico publicado en 2017